These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38369639)

  • 1. Approaches to Design an Efficient, Predictable Global Post-approval Change Management System that Facilitates Continual Improvement and Drug Product Availability.
    Vinther A; Ramnarine E; Gastineau T; O'Brien L; Brehm O; Fryrear D
    Ther Innov Regul Sci; 2024 May; 58(3):433-442. PubMed ID: 38369639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Industry One-Voice-of-Quality Solutions Management Review of Post-Approval Changes Guide.
    Vinther A; Mohammed F; Ramnarine E
    PDA J Pharm Sci Technol; 2021; 75(5):454-457. PubMed ID: 33723006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solving the Global Continual Improvement and Innovation Challenge: How an Effective Pharmaceutical Quality System Can Transform Post-Approval Change Management.
    Vinther A; Ramnarine E
    PDA J Pharm Sci Technol; 2019; 73(5):517-521. PubMed ID: 31420505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Industry One-Voice-of-Quality (1VQ) Solutions: Effective Management of Post-Approval Changes in the Pharmaceutical Quality System (PQS)-through Enhanced Science and Risk-Based Approaches.
    Ramnarine E; Vinther A; Bruhin K; Tovar C; Colao M
    PDA J Pharm Sci Technol; 2020; 74(4):456-467. PubMed ID: 32467177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Worldwide Regulatory Reliance: Launching a Pilot on a Chemistry, Manufacturing, and Control Post Approval Change for a Vaccine.
    Gastineau T; Ban C; Basso A; Brehme F; Silva AL; Faure O; Palaire LL; Persaud P; Rodriguez H
    PDA J Pharm Sci Technol; 2024 Aug; 78(4):388-398. PubMed ID: 37973190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Path Forward to Optimise Post-approval Change Management and Facilitate Continuous Supply of Medicines and Vaccines of High Quality Worldwide : Joint Position from EFPIA, IFPMA and Vaccines Europe.
    Deavin A; Adam S; Ausborn S; Nielsen ASB; Cappellini S; Colmagne-Poulard I; Gastineau T; Gonzalez-Martinez A; Meillerais S; Mortazavi C
    Ther Innov Regul Sci; 2023 Jan; 57(1):7-11. PubMed ID: 35917091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Global Industry Survey on Post-Approval Change Management and Use of Reliance.
    Deavin A; Hossain A; Colmagne-Poulard I; Wong KC; Perea-Vélez M; Cappellini S; Ausborn S; Meillerais S; Bourguignon C
    Ther Innov Regul Sci; 2024 Nov; 58(6):1094-1107. PubMed ID: 39179719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postmarketing all-case surveillance trends and contribution to safety measures of drugs approved in Japan: a cross-sectional survey in 1999-2019.
    Nakao M; Nakamura Y; Shimokawa M; Maeda H
    Int J Clin Pharm; 2023 Feb; 45(1):108-116. PubMed ID: 36323961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Proposal of a Combined Convergence Regulatory Strategy Applied to Post-approval Changes by Latin American Countries, Reducing Workload and Allowing Continuous Improvement to Guarantee the Quality, Safety, and Efficacy of Medicines.
    Rodriguez H; De Lucia ML
    Front Med (Lausanne); 2021; 8():768376. PubMed ID: 34888329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unleashing the Power of Reliance for Post-Approval Changes: A Journey with 48 National Regulatory Authorities.
    Mangia F; Lin YM; Armando J; Dominguez K; Rozhnova V; Ausborn S
    Ther Innov Regul Sci; 2024 Nov; 58(6):997-1005. PubMed ID: 39048766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alignment in post-approval changes (PAC) guidelines in emerging countries may increase timely access to vaccines: An illustrative assessment by manufacturers.
    Dellepiane N; Pagliusi S; Akut P; Comellas S; De Clercq N; Ghadge S; Gastineau T; McGoldrick M; Nurnaeni I; Scheppler L;
    Vaccine X; 2020 Dec; 6():100075. PubMed ID: 32995745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Sponsor's Perspective on the Contribution of Regulatory-Required Observational Post-Marketing Studies to Understanding Human Drug Product Benefit/Risk in Japan.
    Wolter KD; Kamatani A; Suzuki Y; Imaeda T; Dagher R; Safferman A; Junor R
    Pharmaceut Med; 2024 May; 38(3):217-224. PubMed ID: 38555545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postmarketing Surveillance Studies-An Industry Perspective on Changing Global Requirements and Implications.
    Haque A; Daniel S; Maxwell T; Boerstoel M
    Clin Ther; 2017 Apr; 39(4):675-685. PubMed ID: 28392076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medicinal Product Development and Regulatory Agilities Implemented During the Early Phases of the COVID-19 Pandemic: Experiences and Implications for the Future-An Industry View.
    Geraci G; Bernat J; Rodier C; Acha V; Acquah J; Beakes-Read G
    Ther Innov Regul Sci; 2023 Sep; 57(5):940-951. PubMed ID: 37266868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PDA PAC iAM 2017 Survey on Post Approval Change: Is the Regulatory Environment Hindering Much-Needed Innovation in the Pharma Industry?
    ; Ramnarine E; Busse U; Colao M; Edwards J; Follman K; Gale K; Good K; Kiani S; Jornitz M; Munk M; O'Donnel K; Seymour M; Simianu M; Skeens L; Vinther A; Baker D; Levy R
    PDA J Pharm Sci Technol; 2017; 71(5):421-427. PubMed ID: 28819050
    [No Abstract]   [Full Text] [Related]  

  • 17. The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.
    Amanpour S
    Arch Razi Inst; 2021 Mar; 76(1):1-6. PubMed ID: 33818952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Managing Excipient Supplier Name and Address Changes in the Pharmaceutical Quality System.
    Rolke R; Ramnarine E; Vinther A; Sawant A
    PDA J Pharm Sci Technol; 2020; 74(2):286-288. PubMed ID: 32179712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. WHO implementation workshop on guidelines on procedures and data requirements for changes to approved biotherapeutic products, Seoul, Republic of Korea, 25-26 June 2019.
    Wadhwa M; Kang HN; Jivapaisarnpong T; ; Andalucia LR; Blades CDRZ; Casas Levano M; Chang W; Chew JY; Chilufya MB; Chirachanakul P; Cho HG; Cho YO; Choi KM; Chong S; Chua HM; Farahani AV; Gencoglu M; Ghobrial MRW; Guha P; Gutierrez Lugo MT; Ha SB; Habahbeh S; Hamel H; Hong Y; Iarutkin A; Jang H; Jayachandran R; Jivapaisarnpong T; Kang HN; Kim DY; Kim GH; Kim Y; Kwon HS; Larsen J; Lee AH; Lee J; Medvedeva K; Munkombwe Z; Oh I; Park J; Park J; Putri DE; Rodgers J; Ryu S; Savkina M; Schreitmueller T; Semeniuk O; Seo M; Shin YI; Shin J; Srivastava S; Song H; Song S; Tavares Neto J; Wadhwa M; Yamaguchi T; Youn HD; Yun M
    Biologicals; 2020 May; 65():50-59. PubMed ID: 31959504
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.